IDOGEN — Idogen AB Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- SEK12.58m
- SEK9.60m
Annual cashflow statement for Idogen AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -27.6 | -32.7 | -26.8 | -38.9 | -47.8 |
| Depreciation | |||||
| Non-Cash Items | — | — | — | — | 0.141 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 16.2 | -8.18 | -2.58 | -2.75 | -4.09 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -10.4 | -35 | -28.1 | -40.2 | -50.7 |
| Capital Expenditures | -2.88 | -0.11 | — | -0.51 | -1.64 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.831 | -0.513 | — | — | 1.71 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Change in Net Intangibles | |||||
| Cash from Investing Activities | -3.71 | -0.623 | — | -0.51 | 0.071 |
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 38.8 | 0 | 49.1 | 9.22 | 40.4 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 24.7 | -35.6 | 21 | -31.5 | -10.3 |